Agribody Technologies, Inc.

Agribody Technologies, Inc.

Signal active

Organization

Contact Information

Overview

Agribody Technologies is a agricultural biotechnology company with patented technology that pinpoints and knocks down the gene that causes quick decay in perishable crops, resulting in 3X - 4X longer shelf life, more tolerance to stress, and up to 40% higher yields. CRISPR genome editing is the technical breakthrough enabling our precise novel plant trait development at low cost and high scalability, providing solutions for agricultural crop loss and food waste. We license and co-develop our technology.

About

Industries

Biotechnology, Intellectual Property, Genetics

Founded

2015

Employees

1-10

Headquarters locations

United States, North America

Social

N/A

Profile Resume

Agribody Technologies, Inc. headquartered in United States, North America, operates in the Biotechnology, Intellectual Property, Genetics sector. The company focuses on Biotechnology and has secured $38.4M in funding across 24 round(s). With a team of 1-10 employees, Agribody Technologies, Inc. is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Agribody Technologies, Inc., raised $1.6M. Discover more about their projects, partnerships, and impact on our platform.

Employees

imagePlace Paul Kreutz

Paul Kreutz

Corporate Counsel

Funding Rounds

Funding rounds

2

Investors

4

Lead Investors

0

Total Funding Amount

$1.6M

Details

2

Agribody Technologies, Inc. has raised a total of $1.6M in funding over 2 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor
2020Seed
2017Seed1.6M

Investors

Agribody Technologies, Inc. is funded by 7 investors.

Investor NameLead InvestorFunding RoundPartners
Jerry Feitelson-FUNDING ROUND - Jerry Feitelson1.6M
Alireza Masrour-FUNDING ROUND - Alireza Masrour1.6M
Agribody Technologies, Inc.-FUNDING ROUND - Agribody Technologies, Inc.1.6M
Lateral Capital Management-FUNDING ROUND - Lateral Capital Management1.6M

Recent Activity

There is no recent news or activity for this profile.